Burkert Pieske

pieske

Univ.-Prof. Dr. med. Burkert Pieske, F.E.S.C., F.A.H.A., F.A.C.C.
Director

Department of Internal Medicine and Cardiology

Charité – Universitätsmedizin Berlin

Campus Virchow-Klinikum

and

Department of Internal Medicine and Cardiology

German Heart Institute Berlin

Endowed Professor of Cardiology at the Berlin Institute of Health

Augustenburger Platz 1 – 13353 Berlin

E: burkert.pieske@charite.de -pieske@dhzb.de

T: +49 (0)30 450 553 702 – +49 (0)30 45932400

Burkert Pieske

 

Date of birth 28.04.1961, Heidelberg, Germany

 

Professional Career

  • Since 2019: Coordinator, BIH BeLOVE cohort project (www.bihealth.org/de/forschung/projekte/belove)
  • Since 2019: Deputy Speaker, German Center for Cardiovascular research (DZHK), Standort Berlin, Germany
  • Since 2015: President, Berlin-Brandenburgische Gesellschaft für Herz-Kreislaufforschung e.V.
  • 2007–2014: Full Professor of Cardiology and Head, Department of Cardiology, Medical University of Graz, Austria
  • 2007–2014: Director, Ludwig Boltzmann Institute for Translational Heart Failure Research Austria
  • 2007–2014: Director, University Heart Center, Medical University, Graz, Austria
  • Visiting Professor and Head, Clinical Research Program. Department of Cardiology, University of Göttingen, Germany
  • 2001 – 2007: Associate Professor (APL) and Senior consultant, Department of Cardiology and Pneumology, University of Göttingen, Germany
  • 1998 – 2000: Senior consultant, Department of Cardiology and Pneumology, University of Göttingen, Germany
  • 1990 – 1997: Clinical Training, Department of Internal Medicine/Cardiology and Angiology, Albert-Ludwigs University of Freiburg, Germany
  • 1987 – 1989: Research Associate, Ludwig Maximilian University of Munich, Germany

 

Advanced academic qualifications

  • 1998: Specialisation in Cardiology
  • 1998: Habilitation in Internal Medicine, Albert-Ludwigs-University of Freiburg, Germany
  • 1997: Specialisation in Internal Medicine
  • 1989: Doctorate in Experimental Cardiology, Ludwig Maximilian University of Munich, Germany
  • 1989-1996: Research fellowships:
  • October 1989 – February 1990: National Children´s Hospital Research Center, Tokio, Japan
  • September – December 1991: Harvard Medical School, Boston, USA
  • June – October 1993: Univ. of Washington, Seattle, USA
  • October – December 1995 and April – June 1996: Loyola University, Chicago, USA
  • 1985-1986: United States Medical Licensing Examination, Part I and II

University training and degree

  • 1980 – 1987 Medicine (M.D.), Ludwig Maximilian University of Munich, Germany
  • 1984-1985 Université René Descartes, Paris, France

 

Research interests

  • Clinical: Clinical trials in heart failure, arrhythmias, and cardiogenic shock; Biomarker Research including –omics in cardiovascular disease; Echocardiography Core Lab; Clinical cohorts for early remodelling and disease progression; Registries
  • Experimental and Translational:
  • Cellular and molecular cardiology; Pathophysiology of heart failure and arrhythmias; Translational research in the field of cardiac remodelling, microcirculation and arrhythmias

 

Clinical interests

  • Interventional cardiology; intensive care medicine; primary and secondary prevention; heart failure clinics

 

Research projects (examples)

  • BIH BeLOVE (Berlin Longterm Observation of Vascular Events)
  • EU-H2020 BETA3_LVH (Structural Heart Disease)
  • DZHK SPIRIT-HF (Spironolactone in heart failure with preserved EF)
  • EU-FP7 OPTIM-Ex (Exercise training in Heart Failure with preserved Ejection Fraction)
  • EU-FP7 HOMAGE (Biomarkers for targeted therapies in heart failure)
  • Coordinator, EU-FP7 sysVASC (Systems Medicine in Vascular Disease)
  • Coordinator, EU FP6 CONTICA (Control of intracellular Calcium and Arrhythmias)
  • Graz Heart Study (FFG-Project BioPersMed)

 

Review activity

European Heart Journal, JAMA, Circulation, Circulation Research, American Journal of Physiology, Journal of Molecular and Cellular Cardiology, Cardiovascular Research, Journal of Cardiovascular Pharmacology and Therapeutics, Basic Research in Cardiology, European Journal of Heart Failure, JACC HF, and more.

Continuous review activity for numerous funding organizations and academic institutions. Reviewer (Guidelines and Recommendations), European Society of Cardiology